The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2014

Filed:

Jul. 24, 2012
Applicants:

Douglas R. Savage, Del Mar, CA (US);

Ronald E. Betts, La Jolla, CA (US);

Inventors:

Douglas R. Savage, Del Mar, CA (US);

Ronald E. Betts, La Jolla, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B05D 3/12 (2006.01); B05D 3/10 (2006.01); A61L 33/00 (2006.01); A61F 2/06 (2013.01); A61L 31/16 (2006.01); A61F 2/91 (2013.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61F 2/91 (2013.01); A61L 2300/416 (2013.01);
Abstract

A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating.


Find Patent Forward Citations

Loading…